What can pharmacists do to optimize patient outcomes and curb antimicrobial resistance? Perspectives of current and future practices in Canada
- At: 2010 FIP Congress in Lisbon (Portugal)
- Type: Presentation
- By: THIRION, Daniel (University of Montreal, Montreal, Canada)
Bacterial resistance to antibiotics may increase mortality particularly in patients at high risk of complications most likely by delays in initiating appropriate therapy. Increasing resistance rates in given populations modifies agent selection in empiric settings. These practice changes have been associated with emerging diseases and drug.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.